Neuraxpharm expands outside Europe into Brazil and Mexico
Recently acquired Sanofi portfolio products to be combined with acquired Libber Pharma infrastructure to build new affiliate in Brazil
Products in Mexico to be distributed through newly established greenfield affiliate
Barcelona and Düsseldorf – July 11, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, today announces the establishment of affiliates in Brazil and Mexico, the two largest pharmaceutical markets in Latin America[1], as first steps in its expansion outside of Europe.
[1] Source: IQVIA 2022
